These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16106957)

  • 1. [Synthesis of radiological models and radiological invariants (constants). Part 1].
    Klepper L Ia
    Med Tekh; 2005; (3):27-32. PubMed ID: 16106957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of radiological models and radiological invariants (constants). Part 2].
    Klepper LIa
    Med Tekh; 2006; (1):23-7. PubMed ID: 16610282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis of radiological models and radiological constants. Part 4: Synthesis of population-phenomenological models and Lyman model].
    Klepper LIa
    Med Tekh; 2006; (5):36-40. PubMed ID: 17133945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of radiological models and radiological invariants (constants). (Part 3: synthesis of population-phenomenological models and Klepper model)].
    Klepper LIa
    Med Tekh; 2006; (3):22-6. PubMed ID: 16875141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Method of calculating the probability of radiation-induced complications in organs and tissues in relation to volume of radiation and dose fractionation].
    Klepper LIa
    Med Tekh; 1997; (2):24-7. PubMed ID: 9213735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.
    Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
    Radiother Oncol; 2007 Mar; 82(3):308-16. PubMed ID: 17224197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mathematical modeling of the optimal dose fields in radiation therapy of malignant tumors. Part 1 (Distance radiotherapy)].
    Klepper LIa
    Med Tekh; 2004; (1):30-7. PubMed ID: 15080005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
    Keall PJ; Webb S
    Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Formation of optimum dose fields in contact radiation therapy of malignant tumors].
    Klepper LIa
    Med Tekh; 2003; (2):38-44. PubMed ID: 12924220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Approximate methods for calculation of the likelihood of radiation-induced complications. 1. ACLRC method. 2. CERC method].
    Klepper LIa
    Med Tekh; 2001; (6):12-8. PubMed ID: 11837187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
    Alexander MA; Brooks WA; Blake SW
    Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.
    El Naqa I; Suneja G; Lindsay PE; Hope AJ; Alaly JR; Vicic M; Bradley JD; Apte A; Deasy JO
    Phys Med Biol; 2006 Nov; 51(22):5719-35. PubMed ID: 17068361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical models and simpler dosimetric descriptors of radiation late toxicity.
    Kong FM; Pan C; Eisbruch A; Ten Haken RK
    Semin Radiat Oncol; 2007 Apr; 17(2):108-20. PubMed ID: 17395041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-factor calculations for mouse models using Monte-Carlo simulations.
    Bitar A; Lisbona A; Bardiès M
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):343-51. PubMed ID: 17538523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An interactive method for optimization of irradiation plans in radiation therapy of malignant tumors].
    Klepper LIa
    Med Tekh; 2006; (6):25-30. PubMed ID: 17290922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of radiotherapy using biological parameters.
    Kim Y; Tomé W
    Cancer Treat Res; 2008; 139():257-78. PubMed ID: 18236720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-effect models for risk-relationship to cell survival parameters.
    Daşu A; Toma-Daşu I
    Acta Oncol; 2005; 44(8):829-35. PubMed ID: 16332590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.